Gothenburg, Sweden

Per Arvid Carlsson

This inventor holds 1 USPTO granted patent. Top assignee: Aktiebolaget Hassle. Active years: 1976.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Per Arvid Carlsson: Innovator in Pharmaceutical Chemistry

Introduction

Per Arvid Carlsson is a notable inventor based in Gothenburg, Sweden. He is recognized for his significant contributions to pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications in treating heart diseases. His work has had a lasting impact on the field of medicine.

Latest Patents

Carlsson holds a patent for "Phenoxy-hydroxypropylamines, their preparation, and method." This patent includes para-substituted phenoxy-hydroxypropylamines, which are characterized by their ability to selectively block the .beta.-receptors of the heart. The pharmaceutical preparations derived from these compounds are designed to be effective in treating heart diseases in both animals and humans. His innovative approach has led to the discovery of new compounds that are essential in the medical field.

Career Highlights

Throughout his career, Carlsson has been associated with Aktiebolaget Hassle, where he has made significant strides in pharmaceutical research. His dedication to advancing medical science has earned him recognition among his peers and in the industry.

Collaborations

Carlsson has worked alongside esteemed colleagues such as Stig Ake Carlsson and Bengt Arne Ablad. Their collaborative efforts have contributed to the advancement of pharmaceutical innovations and have fostered a productive research environment.

Conclusion

Per Arvid Carlsson's contributions to pharmaceutical chemistry and his innovative patents have made a significant impact on the treatment of heart diseases. His work continues to influence the field and improve patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…